drug delivery

amyloid plaque alzheimers brain
Research

Denali Alzheimer's antibody clears plaques without ARIA in mice

The Bay Area biotech plans to bring an optimized form of the antibody, which targets beta amyloid, into the clinic in 2026.
Darren Incorvaia Aug 7, 2025 2:00pm
Closeup of blue eye on black background

Boehringer pens $1B pact to reduce eye drug injections

Jul 28, 2025 8:48am
robots deal handshake AI

Daiichi taps Nosis to deliver RNA therapies beyond the liver

Mar 11, 2025 10:24am
Three blocks displaying from left to right a person a handshake and another person

Novo bets up to $354M per target on Gensaic’s delivery tech

Mar 3, 2025 8:37am
Graphic image of a pen signing a signature while two strangelooking business people cheer

Oncology biotech licenses Genevant tech for up to $123M

Dec 20, 2024 6:00am
Three tacos on a white countertop with lime slices next to them

2 biotechs shed staff, fuse to form genetic medicine company

Dec 11, 2024 7:00am